Mesothelioma laboratory tests: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:
==Laboratory Findings==
==Laboratory Findings==
===Pleural Fluid Analysis===
===Pleural Fluid Analysis===
*Pleural fluid analysis, via [[thoracentesis]], may be performed to help in the diagnosis of pleural mesothelioma.<ref name="pmid1914546">{{cite journal| author=Gottehrer A, Taryle DA, Reed CE, Sahn SA| title=Pleural fluid analysis in malignant mesothelioma. Prognostic implications. | journal=Chest | year= 1991 | volume= 100 | issue= 4 | pages= 1003-6 | pmid=1914546 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1914546  }} </ref><ref name="pmid1914546">{{cite journal| author=Gottehrer A, Taryle DA, Reed CE, Sahn SA| title=Pleural fluid analysis in malignant mesothelioma. Prognostic implications. | journal=Chest | year= 1991 | volume= 100 | issue= 4 | pages= 1003-6 | pmid=1914546 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1914546  }}</ref>
*Pleural fluid analysis, via [[thoracentesis]], may be performed to help in the diagnosis of pleural mesothelioma.<ref name="pmid1914546">{{cite journal| author=Gottehrer A, Taryle DA, Reed CE, Sahn SA| title=Pleural fluid analysis in malignant mesothelioma. Prognostic implications. | journal=Chest | year= 1991 | volume= 100 | issue= 4 | pages= 1003-6 | pmid=1914546 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1914546  }} </ref>
*Pleural mesothelioma is associated with decreased pleural pH (< 7.30) and decreased pleural fluid/serum glucose ratios.
*Pleural mesothelioma is associated with decreased pleural pH (< 7.30) and decreased pleural fluid/serum glucose ratios.
*Pleural fluid cytology may or may not be positive for mesothelioma.<ref name="pmid24920946">{{cite journal| author=Na MJ| title=Diagnostic tools of pleural effusion. | journal=Tuberc Respir Dis (Seoul) | year= 2014 | volume= 76 | issue= 5 | pages= 199-210 | pmid=24920946 | doi=10.4046/trd.2014.76.5.199 | pmc=PMC4050067 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24920946  }} </ref>
*Pleural fluid cytology may or may not be positive for mesothelioma.<ref name="pmid24920946">{{cite journal| author=Na MJ| title=Diagnostic tools of pleural effusion. | journal=Tuberc Respir Dis (Seoul) | year= 2014 | volume= 76 | issue= 5 | pages= 199-210 | pmid=24920946 | doi=10.4046/trd.2014.76.5.199 | pmc=PMC4050067 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24920946  }} </ref>
===Serum Biomarker===


===Fluorescence In Situ Hybridization (FISH)===
===Fluorescence In Situ Hybridization (FISH)===

Revision as of 15:49, 19 March 2018

Mesothelioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mesothelioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Summary of Treatment for Pleural Mesothelioma

Summary of Treatment for Peritoneal Mesothelioma

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mesothelioma laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mesothelioma laboratory tests

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mesothelioma laboratory tests

CDC on Mesothelioma laboratory tests

Mesothelioma laboratory tests in the news

Blogs on Mesothelioma laboratory tests

Directions to Hospitals Treating Mesothelioma

Risk calculators and risk factors for Mesothelioma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Laboratory findings consistent with the diagnosis of mesothelioma include abnormal pleural fluid analysis (decreased pleural pH and pleural fluid/serum glucose ratio).The presence of serum biomarker megakaryocyte potentiating factor (MPF) is suggestive of malignant mesothelioma.

Laboratory Findings

Pleural Fluid Analysis

  • Pleural fluid analysis, via thoracentesis, may be performed to help in the diagnosis of pleural mesothelioma.[1]
  • Pleural mesothelioma is associated with decreased pleural pH (< 7.30) and decreased pleural fluid/serum glucose ratios.
  • Pleural fluid cytology may or may not be positive for mesothelioma.[2]

Serum Biomarker

Fluorescence In Situ Hybridization (FISH)

References

  1. Gottehrer A, Taryle DA, Reed CE, Sahn SA (1991). "Pleural fluid analysis in malignant mesothelioma. Prognostic implications". Chest. 100 (4): 1003–6. PMID 1914546.
  2. Na MJ (2014). "Diagnostic tools of pleural effusion". Tuberc Respir Dis (Seoul). 76 (5): 199–210. doi:10.4046/trd.2014.76.5.199. PMC 4050067. PMID 24920946.
  3. 3.0 3.1 Savic S, Franco N, Grilli B, Barascud Ade V, Herzog M, Bode B; et al. (2010). "Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology". Chest. 138 (1): 137–44. doi:10.1378/chest.09-1951. PMID 20139227.


Template:WikiDoc Sources